Cargando…
PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt
Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular...
Autores principales: | Uche, Uzodinma U., Piccirillo, Ann R., Kataoka, Shunsuke, Grebinoski, Stephanie J., D’Cruz, Louise M., Kane, Lawrence P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279406/ https://www.ncbi.nlm.nih.gov/pubmed/30429249 http://dx.doi.org/10.1084/jem.20172018 |
Ejemplares similares
-
Translational control analysis by translationally active RNA capture/microarray analysis (TrIP–Chip)
por: Kudo, Kenji, et al.
Publicado: (2010) -
Pik3ip1 Modulates Cardiac Hypertrophy by Inhibiting PI3K Pathway
por: Song, Hong Ki, et al.
Publicado: (2015) -
Downregulation of PIK3IP1 in retinal microglia promotes retinal pathological neovascularization via PI3K-AKT pathway activation
por: Chen, Lushu, et al.
Publicado: (2023) -
Identification of miR-215 mediated targets/pathways via translational immunoprecipitation expression analysis (TrIP-chip)
por: Fesler, Andrew, et al.
Publicado: (2015) -
Anti-Ischemic Effects of PIK3IP1 Are Mediated through Its Interactions with the ET(A)-PI3Kγ-AKT Axis
por: Park, Jei Hyoung, et al.
Publicado: (2022)